CYP17 mutation E305G causes isolated 17,20 lyase deficiency by selectively altering substrate binding
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Cytochrome p450c17 (CYP17) converts the C21 steroids pregnenolone and progesterone to the C19 androgen precursors dehydroepiandrosterone (DHEA) and androstenedione, respectively, via sequential 17alpha-hydroxylase and 17,20-lyase reactions. Disabling mutations in CYP17 cause combined 17alpha-hydroxylase/17,20-lyase deficiency, but rare missense mutations cause isolated loss of 17,20-lyase activity by disrupting interactions of redox partner proteins with CYP17. We studied an adolescent male with clinical and biochemical features of isolated 17,20-lyase deficiency, including micropenis, hypospadias, and gynecomastia, who is homozygous for CYP17 mutation E305G, which lies in the active site. When expressed in HEK-293 cells or Saccharomyces cerevisiae, mutation E305G retains 17alpha-hydroxylase activities, converting pregnenolone and progesterone to 17alpha-hydroxysteroids. However, mutation E305G lacks 17,20-lyase activity for the conversion of 17alpha-hydroxypregnenolone to DHEA, which is the dominant pathway to C19 steroids catalyzed by human CYP17 (the delta5-steroid pathway). In contrast, mutation E305G exhibits 11-fold greater catalytic efficiency (kcat/Km) for the cleavage of 17alpha-hydroxyprogesterone to androstenedione compared with wild-type CYP17. We conclude that mutation E305G selectively impairs 17,20-lyase activity for DHEA synthesis despite an increased capacity to form androstenedione. Mutation E305G provides genetic evidence that androstenedione formation from 17alpha-hydroxyprogesterone via the minor delta4-steroid pathway alone is not sufficient for complete formation of the male phenotype in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 3 Steroid metabolism in transfected HEK-293 cells. Medium containing 3 H-labeled steroids was incubated with cells transfected with plasmid pcDNA3 containing no insert (empty vector control ( Vc )), wild-type CYP17 cDNA ( WT ), or CYP17 cDNA containing the E305G mutation; the cells were extracted and chromatographed; and autoradiograms of the chromatography plates are shown. A , transfected cells incubated with [ 3 H]progesterone ( left ) or [ 3 H]17 𝛂 -hydroxyprogesterone ( right ). The migration positions of substrates and metabolites are indicated. Prog , progesterone; AD , androstenedione; 17Prog , 17 𝛂 -hydroxyprogesterone. B , transfected cells incubated with [ 3 H]pregnenolone ( left ) or [ 3 H]17 𝛂 -hydroxypregnenolone ( right ). The migration positions of substrates and metabolites are indicated. Preg , pregnenolone; 17Preg , 17 𝛂 -hydroxypregnenolone.](https://figures.cochat.ai/paper-figures/c1249e0b1fa54409afb697faa14bc692/cyp17-mutation-e305g-causes-isolated-17-20-lyase-deficiency-by-selectively-figure-3.png)


![FIG. 5 Lineweaver-Burk plot of [ 3 H]pregnenolone 17 𝛂 -hydroxylation by yeast microsomes containing CYP17 mutation E305G in the presence of 17 𝛂 -hydroxysteroids. Microsomes from yeast strain YiV(B) expressing CYP17 mutation E305G were incubated with [ 3 H]pregnenolone and 2 𝛍 l of ethanol vehicle ( + EtOH ; f ) or with either 40 𝛍 M 17 𝛂 -hydroxypregnenolone ( 17Preg ; ● ) or 20 𝛍 M 17 𝛂 -hydroxyprogesterone ( 17Prog ; Œ ) both added in 2 𝛍 l of ethanol. Lines were drawn by least-squares fits of the data points ( r ≥ 0.99 in all cases), where each data point represents the mean ± S.D. of three independent experiments (some error bars are unseen because they lie within the data points). Lines intersect at the y intercepts , allowing calculation of KI (app) values for competitive inhibition (Table III). The inset shows the type I difference spectrum obtained when a suspension of yeast expressing mutation E305G was incubated with 10 𝛍 M 17 𝛂 -hydroxyprogesterone. Error bar , 0.02 absorbance units.](https://figures.cochat.ai/paper-figures/312b611571b943c79cad3572a9cb6c0d/cyp17-mutation-e305g-causes-isolated-17-20-lyase-deficiency-by-selectively-figure-5.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“By contrast, the P450c17 mutation E305G causes 17,20-lyase deficiency by selectively disrupting binding of 17␣-hydroxypregnenolone and preventing DHEA synthesis despite enhanced conversion of 17OHP to androstenedione (282).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“As in the adrenal, the principal pathway to C 19 -steroids is via ⌬ 5 steroids to DHEA; the ⌬ 4 pathway from 17OHP to androstenedione makes a minimal contribution (238, 282).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [282]
In the citing paper
“Testicular androgen biosynthesis is carried out in the Leydig cells and, similar to the adrenal, follows the classical Δ5 pathway with only minor contribution of the Δ4 pathway (Fluck et al., 2003, Sherbet et al., 2003).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Sherbet et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194
[6] Yeast expression of animal and plant P450s in optimized redox environments
Pompon, D., Louerat, B., Bronine, A., & Urban, P. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)72008-6 · Cited by 653
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationChung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
Alani, E., Cao, L., & Kleckner, N. (1987) · Genetics · doi:10.1093/genetics/116.4.541 · Cited by 417
Williams Textbook of Endocrinology
Stoffer, S. S. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390110105044 · Cited by 404
17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition
YANASE, T., SIMPSON, E. R., & WATERMAN, M. R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-91 · Cited by 390
Imai, M., Shimada, H., Watanabe, Y., Matsushima-Hibiya, Y., Makino, R., Koga, H., Horiuchi, T., & Ishimura, Y. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7823 · Cited by 373
Total biosynthesis of hydrocortisone from a simple carbon source in yeast
Szczebara, F. M., Chandelier, C., Villeret, C., Masurel, A., Bourot, S., Duport, C., Blanchard, S., Groisillier, A., Testet, E., Costaglioli, P., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt775 · Cited by 326
Research works printed but not linked: 7
- 7. Lin, D., Black, S. M., Nagahama, Y., and Miller, W. L. (1993) Endocrinology 132, 2498 -2506 · doi:10.1210/endo.132.6.8504753 · Paper page
- 11. Youngblood, G. L., and Payne, A. H. (1992) Mol. Endocrinol. 6, 927-934
- 14. Biglieri, E. G., Herron, M. A., and Brust, N. (1966) J. Clin. Investig. 15, 1945-1954
- 17. Miura, K., Yasuda, K., Yanase, T., Yamakita, N., Sasano, H., Nawata, H., Inoue, M., Fukaya, T., and Shizuta, Y. (1996) J. Clin. Endocrinol. Metab. 81, 3797-3801
- 21. Auchus, R. J., and Miller, W. L. (1999) Mol. Endocrinol. 13, 1169 -1182
- 25. Costa-Santos, M., Auchus, R. J., and Kater, C. E. (2003) J. Clin. Endocrinol. Metab., in press
- 32. Lee-Robichaud, P., Akhtar, M. E., and Akhtar, M. (1999) Biochem. J. 342, 309 -312 · doi:10.1042/bj3420309 · Paper page
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Aetiology of hypospadias: a systematic review of genes and environment
van der Zanden, L. F. M., van Rooij, I. A. L. M., Feitz, W. F. J., Franke, B., Knoers, N. V. A. M., & Roeleveld, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms002 · Cited by 292
Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
Self-citationIntracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“Testicular androgen biosynthesis is carried out in the Leydig cells and, similar to the adrenal, follows the classical D5 pathway with only minor contribution of the D4 pathway (Fluck et al., 2003; Sherbet et al., 2003).”
Basic concepts and recent developments in human steroid hormone biosynthesis
Ghayee, H. K., & Auchus, R. J. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9052-2 · Cited by 212
“These ILD mutations tend to interfere more with electron transfer [33] but can impair substrate binding [34].”
BackgroundSelf-citationThe syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Cytochrome P450 research and The Journal of Biological Chemistry
Guengerich, F. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.004144 · Cited by 117
“The molecular basis for deficiencies of several P450s has been demonstrated in several inherited diseases, particularly in endocrine dysfunction (107, 108).”
BackgroundThe in vitro modulation of steroidogenesis by inflammatory cytokines and insulin in TM3 Leydig cells
Leisegang, K., & Henkel, R. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0341-2 · Cited by 126
“gonads, adrenal medula and adipose tissue) [13, 16], and testosterone synthesis in males is most prominent in the Leydig cells [16, 18].”
BackgroundThe diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)
Yoshimoto, F. K., & Auchus, R. J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.026 · Cited by 124
“expressing the native enzyme (or mutated variants) in mammalian cells or in yeast together with its redox partners human (or yeast) P450-oxidoreductase (POR) and/or b5 and isolating microsomes with the enzyme system [17].”
MethodSelf-citationIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Marsh, C. A., & Auchus, R. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.011 · Cited by 103
Self-citationSubstrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468926 · Cited by 100
“Secondly, the detection of clinical isolated lyase deficiency associated with some CYP17A1 mutations (39) and the selective enhancement of 17,20-lyase activity by b5 suggest that the two catalytic activities of CYP17A1 can be controlled independently, which is of clinical utility.”
BackgroundMolecular genetics of hypospadias and cryptorchidism recent developments
Kalfa, N., Gaspari, L., Ollivier, M., Philibert, P., Bergougnoux, A., Paris, F., & Sultan, C. (2018) · Clinical Genetics · doi:10.1111/cge.13432 · Cited by 88
“CYP17A1 may also be implicated with altered substrate binding when mutated.(52) Mutations of the 5-alpha reductase gene are”
BackgroundMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Kim, Y., Kang, M., Choi, J., Lee, B. H., Kim, G.-H., Ohn, J. H., Kim, S. Y., Park, M. S., & Yoo, H. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.015 · Cited by 82
Tiosano, D., Knopf, C., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 71
Self-citationEffect of the metabolic syndrome on male reproductive function: a case-controlled pilot study
Leisegang, K., Udodong, A., Bouic, P. J., & Henkel, R. (2012) · Andrologia · doi:10.1111/and.12060 · Cited by 69
“IL-1b-induced hCG-stimulated testosterone inhibition in rat Leydig cells is reversed with the co-culture of an IL-1 antagonist (Sherbet et al., 2003; Hales et al., 2005).”
BackgroundThe next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Self-citationNaffin-Olivos, J. L., & Auchus, R. J. (2006) · Biochemistry · doi:10.1021/bi051623y · Cited by 66
Self-citationSalvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Bhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
Rendic, S. P., & Guengerich, F. P. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1483401 · Cited by 61
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“…affects the active site and directly impairs the conversion of 17-Preg to DHEA, but does not impair 17α-hydroxylase activity when assayed in transfected yeast or mammalian cells (Sherbet et al., 2003), although the affected patients had impaired cortisol responses to ACTH (Tiosano et al., 2008).”
BackgroundThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Peng, H.-M., Im, S.-C., Pearl, N. M., Turcu, A. F., Rege, J., Waskell, L., & Auchus, R. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00532 · Cited by 50
Self-citationThe Physiology and Biochemistry of Adrenarche
Auchus, R. J. (2010) · Endocrine development · doi:10.1159/000321209 · Cited by 55
Self-citationA Novel Point Mutation in P450c17 (CYP17) Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Brooke, A. M., Taylor, N., Shepherd, J. H., Gore, M. E., Ahmad, T., Lin, L., Rumsby, G., Papari-Zareei, M., Auchus, R. J., Achermann, J. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2653 · Cited by 53
“R347H and R358Q) that change the distribution of surface charges on the redox binding site of P450c17 impair electron transfer and can result in isolated 17,20-lyase deficiency with preserved 17 hydroxylase function (8, 9, 13).”
BackgroundMethodSelf-citationDhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 52
Fetal hormones and sexual differentiation
Sobel, V., Zhu, Y.-S., & Imperato-McGinley, J. (2004) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2004.08.005 · Cited by 44
“Isolated 17,20-lyase deficiency was reported as a cause of genital ambiguity of varying degrees in the absence of hypertension in genetic males [83,84].”
BackgroundFernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
“[28] to cause isolated 17,20 lyase deficiency, was later reported by Tiosano et al.”
BackgroundInfluentialStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
P450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 44
Self-citationFunctional expression and characterisation of human cytochrome P45017α in Pichia pastoris
Kolar, N. W., Swart, A. C., Mason, J. I., & Swart, P. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.02.003 · Cited by 46
Ghayee, H. K., Rege, J., Watumull, L. M., Nwariaku, F. E., Carrick, K. S., Rainey, W. E., Miller, W. L., & Auchus, R. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1222 · Cited by 34
Self-citationCatalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5
Peng, H., Liu, J., Forsberg, S. E., Tran, H. T., Anderson, S. M., & Auchus, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608919 · Cited by 42
“Yeast microsomes containing native human CYP17A1 and POR and control microsomes without human P450 enzymes were prepared from strain YiV(B) transformed with V60-c17 or native V60 plasmids, respectively, as described (20).”
MethodSelf-citationCirculating Bioactive Androgens in Midlife Women
Chen, J., Sowers, M. R., Moran, F. M., McConnell, D. S., Gee, N. A., Greendale, G. A., Whitehead, C., Kasim-Karakas, S. E., & Lasley, B. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0284 · Cited by 39
Nguyen, A. D., Mapes, S. M., Corbin, C. J., & Conley, A. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0337 · Cited by 38
Yoshimoto, F. K., Zhou, Y., Peng, H.-M., Stidd, D., Yoshimoto, J. A., Sharma, K. K., Matthew, S., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi300895w · Cited by 38
Self-citationGarrido, M., Peng, H.-M., Yoshimoto, F. K., Upadhyay, S. K., Bratoeff, E., & Auchus, R. J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.013 · Cited by 35
“Microsomes were prepared from an yeast strain that expresses human CYP17A1 and human P450-oxidoreductase (POR), according to the methods described [10].”
MethodSelf-citationAchermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 40
Steroidogenic Enzymes in Leydig Cells
Payne, A. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-453-7_10 · Cited by 39
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Direct electrochemistry of human, bovine and porcine cytochrome P450c17
Johnson, D. L., Conley, A. J., & Martin, L. L. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01971 · Cited by 32
“A point mutation selectively altering 17,20-lyase activity of human P450c17 was recently reported to involve neutralization of a positively charged glutamate residue predicted to lie near the heme in the active site ( Sherbet et al. 2003 ).”
BackgroundKim, D., Kim, V., McCarty, K. D., & Guengerich, F. P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100571 · Cited by 31
“(43), who used an indirect approach to characterizing substrate binding.”
BackgroundResultInfluentialThe broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series
Sun, M., Mueller, J. W., Gilligan, L. C., TAYLOR, A. E. R., Shaheen, F., Noczyńska, A., T'Sjoen, G. G., Denvir, L., Shenoy, S., Fulton, P., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0152 · Cited by 31
“A small number of individuals affected by 17OHD present with apparently isolated 17,20-lyase deficiency, with abolished or severely reduced 17,20-lyase activity but only mild to moderate impairment of 17 α -hydroxylase activity (12, 13, 14).”
Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism
Carmichael, S. L., Witte, J. S., Ma, C., Lammer, E. J., & Shaw, G. M. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00165.x · Cited by 31
“Case reports suggest that mutations in CYP17 or reduced CYP17 activity may be associated with hypospadias and male pseudohermaphroditism (Ammini et al., 1997; Sherbet et al., 2003).”
BackgroundWang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
“Other mutations, such as R347H and R356Q (22), have also selectively reduced lyase activity of P450c17 by affecting the P450c17 domain that interacts with POR (23), and E305G selectively reduced lyase activity directly in the catalytic active site (24), but the mechanism by which mutation of S94 would selectively affe…”
BackgroundPattison, J. C., Abbott, D. H., Wendy Saltzman, A., Conley, A. J., & Bird, I. M. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0554 · Cited by 31
“…is given: membrane (membrane insertion domain); substrate binding (substrate binding domain); redox (POR/CYTB5 binding domain); heme (heme binding domain); NR (not reported) (modified from Biason-Lauber et al. (2000), van den Akker et al. (2002), Martin et al. (2003) and Sherbet et al. (2003)).”
BackgroundMonogenic Forms of Hypertension
Ceccato, F., & Mantero, F. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.009 · Cited by 31
Clinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
Why human cytochrome P450c21 is a progesterone 21-hydroxylase
Mizrachi, D., Wang, Z., Sharma, K. K., Gupta, M. K., Xu, K., Dwyer, C. R., & Auchus, R. J. (2011) · Biochemistry · doi:10.1021/bi102078e · Cited by 28
Self-citationThe Action of Cytochromeb5on CYP2E1 and CYP2C19 Activities Requires Anionic Residues D58 and D65
Peng, H., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi301384n · Cited by 28
Self-citationThe Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Haider, S. M., Patel, J. S., Poojari, C., & Neidle, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.069 · Cited by 27
17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature
Maheshwari, M., Arya, S., Lila, A. R., Sarathi, V., Barnabas, R., Rai, K., Bhandare, V. V., Memon, S. S., Karlekar, M. P., Patil, V. A., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac011 · Cited by 31
“Patients with the diagnosis of apparent isolated 17,20-lyase deficiency (n = 7, from 6 families) [4, 5, 12, 13] were noted, whereas others were classified into combined severe deficiency (female external genitalia) and combined partial deficiency (atypical or male external genitalia) based on the clinical parameters.”
BackgroundSteroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Rare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
Sherbet, D. P., Guryev, O. L., Papari-Zareei, M., Mizrachi, D., Rambally, S., Akbar, S., & Auchus, R. J. (2009) · Endocrinology · doi:10.1210/en.2008-1817 · Cited by 22
Self-citationPediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Shet, M. S., Fisher, C., Tremblay, Y., Bélanger, A., Conley, A. J., Mason, J. I., & Estabrook, R. W. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468391 · Cited by 21
“…was obtained when Kitamura et al. (1991) mutated two amino acids (R347L and R356L) in this region of rat and showed a selective loss of C17,20-lyase activity, although Sherbet et al. (2003) reported a similar selective impairment of 17,20- lyase activity from a point mutation (E305G) of human.”
BackgroundMatsumoto, A. M., & Bremner, W. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00019-8 · Cited by 27
Matsumoto, A. M., & Bremner, W. J. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00019-5 · Cited by 18
Transcriptomic signatures for human male infertility
Hodžić, A., Maver, A., Zorn, B., Petrovič, D., Kunej, T., & Peterlin, B. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1226829 · Cited by 22
Novel P450c17 Mutation H373D Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Sahakitrungruang, T., Tee, M. K., Speiser, P., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0645 · Cited by 21
Leung, M. T., Cheung, H. N., Iu, Y. P. H., Choi, C. H., Tiu, S. C., & Shek, C. C. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz016 · Cited by 18
Successful Delivery in 17,20-Lyase Deficiency
Blumenfeld, Z., & Koren, I. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab222 · Cited by 19
Friedelin, a novel inhibitor of CYP17A1 in prostate cancer from Cassia tora
Joshi, B., Bhandare, V. V., Vankawala, M., Patel, P., Patel, R. K., Vyas, B., & Krishnamurthy, R. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2145497 · Cited by 18
“The other mutation in CYP17A1 that had been reported to selectively impair the 17,20 lyase activity is E305G, which is part of the substrate access channel of CYP17A1 (Liu et al., 2020, 2021; Sherbet et al., 2003; Tiosano et al., 2008).”
BackgroundEpoxidation Activities of Human Cytochromes P450c17 and P450c21
Yoshimoto, F. K., Peng, H., Zhang, H., Anderson, S. M., & Auchus, R. J. (2014) · Biochemistry · doi:10.1021/bi5011865 · Cited by 16
Self-citationZhang, S., Zhang, L., Ru, X., Ding, K., & Feng, Q. (2021) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2021.100790 · Cited by 35
Storbeck, K., Swart, A. C., Snyman, M. A., & Swart, P. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06539.x · Cited by 15
Xenopus laevis CYP17 Regulates Androgen Biosynthesis Independent of the Cofactor Cytochrome b5
Yang, W., & Hammes, S. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411886200 · Cited by 18
Peng, H., & Auchus, R. J. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.11.001 · Cited by 13
Self-citationLiu, Y., Denisov, I. G., Gregory, M. C., Sligar, S. G., & Kincaid, J. R. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00023 · Cited by 13
Panter, B. U., Jose, J., & Hartmann, R. W. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-4508-8 · Cited by 12
“The human embryonic kidney cell line HEK293 is often used for stable and transient expression of enzymes involved in the biosynthesis and metabolism of steroids [2, 3].”
BackgroundAuchus, R. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00008-9 · Cited by 15
Self-citationHahm, J. R., Jung, T. S., Byun, S. Y., Lee, Y. N., Lee, K. H., & Kim, D. R. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.018 · Cited by 12
Witchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 12
Mechanism of the Clinically Relevant E305G Mutation in Human P450 CYP17A1
Liu, Y., Grinkova, Y. V., Gregory, M. C., Denisov, I. G., Kincaid, J. R., & Sligar, S. G. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00282 · Cited by 10
Neres, M. S., Auchus, R. J., Shackleton, C. H. L., & Kater, C. E. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000900009 · Cited by 10
“In this regard, it is tempting to speculate that some patients with “complete 17OHD” may in fact have “isolated 17-hydroxylase deficiency”, in analogy to those with “isolated 17,20-lyase deficiency” reported by Tiosano in whom the E305G mutation in the CYP17A1 gene was shown in vivo to affect also 17-hydroxylation, al…”
ResultSelf-citationUrinary steroid profiling: a powerful method for the diagnosis of abnormal steroidogenesis
Koyama, Y., Homma, K., & Hasegawa, T. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.904199 · Cited by 9
“Some mutations have been reported to cause apparently isolated 17,20-lyase deficiency [36,37], which is characterized by significantly increased B metabolites/Anetiocholanolone (Et) ratio, whereas slightly increased or normal pregnanediol (PD)/20aPT ratio and B/F metabolites ratio.”
BackgroundSynthesis of halogenated pregnanes, mechanistic probes of steroid hydroxylases CYP17A1 and CYP21A2
Yoshimoto, F. K., Desilets, M. C., & Auchus, R. J. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.09.007 · Cited by 10
Self-citationTateishi, Y., Webb, S. N., Li, B., Liu, L., Rose, K. L., Leser, M., Patel, P. R., & Guengerich, F. P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105688 · Cited by 9
Souter, I. C., Munir, I., Mallick, P., Weitsman, S. R., Geller, D. H., & Magoffin, D. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.12.011 · Cited by 10
Wang, Y., Li, J., Li, J., Zhao, Y.-J., & Zhang, D. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.008 · Cited by 9
“[8] Sherbet DP, Tiosano D, Kwist KM, et al.”
BackgroundSteroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic
Salvador, J. A. R., Vania, M., & Silvestre, S. (2013) · InTech eBooks · doi:10.5772/52290 · Cited by 10
Camats, N., Üstyol, A., Atabek, M. E., Dick, B., & Flück, C. E. (2015) · Clinical Case Reports · doi:10.1002/ccr3.343 · Cited by 10
Shaunak, M., Taylor, N. F., Hunt, D., & Davies, J. H. (2020) · Hormone Research in Paediatrics · doi:10.1159/000512372 · Cited by 6
Rare Types of Congenital Adrenal Hyperplasias Other Than 21-hydroxylase Deficiency
İsakoca, M., Erdeve, Ş. S., & Çetinkaya, S. Ç. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-21-s · Cited by 8
“In isolated deficiency of 17,20-lyase enzyme, ambiguous genitalia, micropenis, hypospadias, and gynecomastia may be observed in boys, and puberty delay and absence of adrenarche may be observed in girls (30).”
Genetic Deficiencies of Cytochrome P450c17 (CYP17A1)
Auchus, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00009-0 · Cited by 6
Self-citationZhu, Y., & Imperato‐McGinley, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00067-5 · Cited by 6
A novel mutation in CYP17A1 gene leads to congenital adrenal hyperplasia: A case report
Nazari, M., Mehrjardi, M. Y. V., Neghab, N., Aghabagheri, M., & Ghasemi, N. (2019) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v17i6.4817 · Cited by 6
“Isolated 17,20lyase deficiency (ILD) was first described in boys with a disorder of sex development (DSD) (11, 19).”
BackgroundThe Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Self-citationMo, E. Y., Lee, J., Kim, S. Y., Kim, M. J., Kim, E. S., Lee, S., Han, J. H., & Moon, S. D. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.3.413 · Cited by 6
Metadata
- Authors
- Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Rambam Health Care Campus (IL)
- Meyer Children's Hospital (IL)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 49
- Pages
- 48563-48569
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079050871
- Semantic Scholar
- 5dfcf3def28bf6ef9c8a68830f09df654cd58fc6
- Cited by
- 131
- References
- 47
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 2 · 2019: 6 · 2018: 8 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 4
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6139 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r03dk056641-03, 5k08dk002387-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03-DK-56641, K08 DK 02387)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- CYP17, 17,20-lyase deficiency, P450c17, 17α-hydroxylase, substrate binding, androstenedione, 17-hydroxyprogesterone, male phenotype, congenital adrenal hyperplasia, micropenis, hypospadias, gynecomastia
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Humans, Molecular Sequence Data, Steroid 17-alpha-Hydroxylase, Substrate Specificity, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, DNA Primers, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.